Here you will find all our clinical education resources from articles to recorded webinars, all supporting equitable access to funded medicines.
Medicine affordability is one of the five drivers of medicine access equity.
Up to 40 per cent of people continue to pay prescription copayments even though they are entitled to an exemption. No person or family should pay more than $100 per annum for subsidised medicines.
This list of Q&A reflects issues discussed in webinars held early in 2021.
The content has been edited, and reviewed by Waikato DHB endocrinologist/diabetologist Dr Ryan Paul.
Your patient uses gliclazide and insulin but could still benefit from the additional cardiovascular and renal protections of empagliflozin. How would you manage the change in treatment?
This case study is particularly relevant to prescribers. It originally appeared in the 3 March 2021 issue of New Zealand Doctor Rata Aotearoa and has been republished with permission.
Current management of type 2 diabetes includes two new classes of medication, SGLT2 inhibitors and GLP-1 receptor agonists, where clinically indicated. This article was published in the April 2021 edition of Kai Tiaki. It has been edited specifically for our nursing readership from an article that appeared in New Zealand Doctor and Pharmacy Today late in 2020.
This article is endorsed by the College of Nurses Aotearoa (NZ) Inc.
Capture, a new online tool, will help He Ako Hiringa members keep track of what they’re learning online.
Clicking the Capture button at the bottom of each educational piece will create a record of the time taken to read, watch or listen to that content. Members will also be able to record their thoughts and reflections on the content, creating a Capture Record that can then be downloaded and used as a record of learning.
Health inequities in the detection and management of diabetes and its associated health outcomes are significant concerns in New Zealand. The first step to addressing inequitable health outcomes is knowing that they exist.
In this webinar, Dr Ryan Paul discusses the changes to type 2 diabetes care in 2021, including when and how to use SGLT2 inhibitors and GLP-1 agonists. You can watch the webinar here or in ELearning.
Downloadable empagliflozin patient information and a recent slide presentation can be found within this article.
If you're having trouble pronouncing the name of the newly funded SGLT2 inhibitor for type 2 diabetes, you're not the only one! Watch our video guide to learn how to pronounce empagliflozin.
Inequities exist in all aspects of diabetes care. In this article, Alesha Smith outlines some examples, proposes some actions, and explains where the new medicines fit in.
This activity has been endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and has been approved for up to 0.5 CME credits for the General Practice Educational Programme (GPEP) and Continuing Professional Development (CPD) purposes.
In this webinar, Dr Rinki Murphy discusses the issue of inequity in diabetes care.
In this webinar, Sandy Bhawan and Dr Emily Gill discuss how to improve medicine access equity in primary care. You can watch this webinar here or in ELearning.
The call for equity in healthcare is not new but it is louder than it has ever been before. This article shares the experiences of primary care clinicians around the country as they work to improve medicine access equity for patients. This article is part of a course, which is accredited by PSNZ for Group 2 points for pharmacists and endorsed by CNA(NZ) for 1.5 professional development hours for nurses. It is also suitable for professional development for general practitioners.